IHE vs. AGNG
IHE (iShares U.S. Pharmaceuticals ETF) and AGNG (Global X Aging Population ETF) are both Health & Biotech Equities funds - IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index while AGNG tracks the Indxx Aging Population Thematic Index. Both are passively managed. Over the past 10 years, IHE returned 8.99%/yr vs 9.37%/yr for AGNG. A 0.66 correlation means they provide meaningful diversification when combined. IHE charges 0.42%/yr vs 0.50%/yr for AGNG.
Performance
IHE vs. AGNG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IHE achieves a 11.65% return, which is significantly higher than AGNG's -2.65% return. Both investments have delivered pretty close results over the past 10 years, with IHE having a 8.99% annualized return and AGNG not far ahead at 9.37%.
IHE
- 1D
- 1.60%
- 1M
- 3.16%
- YTD
- 11.65%
- 6M
- 10.97%
- 1Y
- 46.87%
- 3Y*
- 18.43%
- 5Y*
- 10.55%
- 10Y*
- 8.99%
AGNG
- 1D
- 0.89%
- 1M
- -2.46%
- YTD
- -2.65%
- 6M
- -3.59%
- 1Y
- 12.53%
- 3Y*
- 8.93%
- 5Y*
- 3.41%
- 10Y*
- 9.37%
IHE vs. AGNG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 11.65% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
AGNG Global X Aging Population ETF | -2.65% | 20.01% | 7.03% | 9.65% | -8.61% | 3.91% | 18.96% | 25.24% | -1.45% | 28.17% |
Correlation
The correlation between IHE and AGNG is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.74 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.72 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.75 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since May 10, 2016 | 0.66 |
The correlation between IHE and AGNG has been stable across timeframes, ranging from 0.66 to 0.75 - a consistent structural relationship.
IHE vs. AGNG - Sectors Allocation Comparison
Sectors
IHE
AGNG
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
Technology
-
-
Utilities
-
-
Healthcare
IHE
AGNG
Basic Materials
IHE
-
AGNG
-
Communication Services
IHE
-
AGNG
-
Consumer Cyclical
IHE
-
AGNG
-
Consumer Defensive
IHE
-
AGNG
-
Energy
IHE
-
AGNG
-
Financial Services
IHE
-
AGNG
-
Industrials
IHE
-
AGNG
-
Real Estate
IHE
-
AGNG
Technology
IHE
-
AGNG
-
Utilities
IHE
-
AGNG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHE vs. AGNG — Risk / Return Rank
IHE
AGNG
IHE vs. AGNG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Global X Aging Population ETF (AGNG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IHE | AGNG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.82 | ||
| Sortino ratioReturn per unit of downside risk | +2.54 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.17 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 5.56 | 1.10 | +4.46 |
| Martin ratioReturn relative to average drawdown | 17.09 | 2.68 | +14.41 |
Loading charts...
Drawdowns
IHE vs. AGNG - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, which is greater than AGNG's maximum drawdown of -30.58%. Use the drawdown chart below to compare losses from any high point for IHE and AGNG.
Loading charts...
Drawdown Indicators
| IHE | AGNG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.20% | -30.58% | -7.62% |
Max Drawdown (1Y)Largest decline over 1 year | -8.47% | -11.45% | +2.98% |
Max Drawdown (3Y)Largest decline over 3 years | -15.92% | -14.48% | -1.44% |
Max Drawdown (5Y)Largest decline over 5 years | -16.03% | -25.66% | +9.63% |
Max Drawdown (10Y)Largest decline over 10 years | -29.59% | -30.58% | +0.99% |
Current DrawdownCurrent decline from peak | -0.70% | -9.10% | +8.40% |
Average DrawdownAverage peak-to-trough decline | -7.90% | -5.97% | -1.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.75% | 4.68% | -1.93% |
Volatility
IHE vs. AGNG - Volatility Comparison
iShares U.S. Pharmaceuticals ETF (IHE) has a higher volatility of 5.27% compared to Global X Aging Population ETF (AGNG) at 4.39%. This indicates that IHE's price experiences larger fluctuations and is considered to be riskier than AGNG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IHE | AGNG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.27% | 4.39% | +0.88% |
Volatility (6M)Calculated over the trailing 6-month period | 12.68% | 10.31% | +2.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.22% | 13.70% | +3.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.28% | 15.23% | +1.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.05% | 17.14% | +0.91% |
IHE vs. AGNG - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is lower than AGNG's 0.50% expense ratio.
Dividends
IHE vs. AGNG - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.56%, more than AGNG's 0.90% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGNG Global X Aging Population ETF | 0.90% | 0.88% | 0.83% | 0.96% | 0.49% | 0.72% | 0.36% | 0.83% | 1.00% | 1.04% | 0.45% | 0.00% |
IHE iShares U.S. Pharmaceuticals ETF | 1.56% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
Frequently Asked Questions
IHE and AGNG have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHE has higher volatility (5.27%) compared to AGNG (4.39%). In terms of maximum drawdown, IHE dropped -38.20% vs AGNG's -30.58%.
On 10-year performance, AGNG leads with 9.37% vs 8.99% for IHE. On fees, IHE is cheaper at 0.42% per year. On volatility, AGNG has been the lower-risk option at 4.39%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, AGNG has performed better with a 9.37% return vs 8.99%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHE is cheaper with a 0.42% expense ratio, compared with 0.50% for AGNG.
IHE has the higher dividend yield at 1.56%, compared with 0.90% for AGNG.
IHE tracks Dow Jones U.S. Select Pharmaceuticals Index, while AGNG tracks Indxx Aging Population Thematic Index. They also come from different issuers: iShares and Global X. Their fees differ too: 0.42% for IHE and 0.50% for AGNG.
IHE currently has the higher Sharpe Ratio (2.74 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IHE and AGNG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer